Hudson Pacific Properties is a holding company. Through its subsidiaries, the company is a self-administered and self-managed real estate investment trust focused on acquiring, repositioning, developing and operating office and studio properties in submarkets throughout Northern and Southern California and the Pacific Northwest. The company owns its interests in all of its properties and conducts substantially all of its business through its operating partnership, Hudson Pacific Properties, L.P. The company has two segments: office properties, which are located in Northern and Southern California and the Pacific Northwest; and studio properties, which are located in Southern California.

Innovative Solutions and Support is a systems integrator that designs, develops, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, autothrottles and cockpit display systems for retrofit applications and original equipment manufacturers (OEMs). The company supplies Flight Management Systems, Flat Panel Display Systems, Autothrottle Systems, air data equipment, Integrated Standby Units and Global Positioning System receivers that enable reduced carbon footprint navigation. The company sells to both the OEM and the retrofit markets.

Medpace Holdings is a holding company. Through its subsidiaries, the company is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company provides a range of services supporting the clinical development process from Phase I to Phase IV. The company provides these services across a range of therapeutic areas. The company's line of clinical development services includes, but is not limited to, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, medical writing, data management, pharmacovigilance, and molecular and genetic testing.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.